Icona dell'app AgingResearch.News: Longevity

The fastest way to know what really works in longevity

Di PAPERFOOT AI PTE. LTD. · Social
Punteggio Debuts 76NuovaSii il primo a valutarla

Perché ce lo aspettiamo: Clear, well-documented value for longevity researchers, with evidence-focused descriptions and useful follow and alert features.

Screenshot 1 di AgingResearch.News: LongevityScreenshot 2 di AgingResearch.News: LongevityScreenshot 3 di AgingResearch.News: LongevityScreenshot 4 di AgingResearch.News: LongevityScreenshot 5 di AgingResearch.News: Longevity

App simili in Social

Vedi le migliori

In breve

AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.

Riepilogo di Debuts, basato sulla scheda dell'App Store.

Informazioni

The fastest way to know what really works in longevity.

AgingResearch.News scans the world’s ageing research in real time: 1,800+ papers an hour from PubMed, bioRxiv, medRxiv, arXiv, Europe PMC and journals worldwide. It reads every one, weighs the evidence and tells you what it found in plain English, with every claim cited. Over 690,000 papers so far.

NEVER MISS A BREAKTHROUGH The papers that matter, ranked on evidence, never on fame. What was studied, in whom, what changed, and the catch, at a glance. Mouse, cell or human: you see it instantly.

FOLLOW WHAT YOU CARE ABOUT Follow a drug, gene, pathway, disease, lab or author, and get an alert the moment a new paper on it lands. Rapamycin, senolytics, NAD+, metformin, GLP-1s, epigenetic clocks, reprogramming: thousands of subjects, each with an evidence profile from cells and mice to human trials.

ASK THE LITERATURE Ask anything about ageing research and get an answer in seconds, drawn from the papers, with the sources to check.

SEE THE FIGURES Every paper’s own figures, a tap away. Save papers to read later, on your phone and on the web.

PLUS For you: your field, ranked for your own research, with a match score on every paper. 20 questions a day to Ask, 5 interests and 25 follows, each with its own alerts, and export to Zotero, EndNote or Mendeley. One subscription works in the app and on agingresearch.news.

PRO Everything in Plus, with 500 questions a day to Ask, 25 interests, unlimited follows and 10 email digests. On agingresearch.news: company profiles, asset records, dashboards, watchlists and the catalyst calendar, 25 Ultradeep reviews a day, due-diligence packs, and the API and MCP server.

Plus and Pro renew automatically unless cancelled at least 24 hours before the period ends. Manage or cancel them in your Apple Account settings.

Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/ Terms: https://agingresearch.news/terms Privacy: https://agingresearch.news/privacy

Domande su AgingResearch.News: Longevity

Che cos'è AgingResearch.News: Longevity?
AgingResearch.News: Longevity scans ageing research papers from sources such as PubMed and bioRxiv, summarises their findings in plain English with citations, and ranks them on evidence. It suits people following longevity science, including researchers, who can follow topics and export references to Zotero, EndNote or Mendeley. It stands out for showing, at a glance, what was studied, in which subjects, and the catch.
AgingResearch.News: Longevity è gratis?
Sì. AgingResearch.News: Longevity si scarica gratis.
Su quali dispositivi funziona AgingResearch.News: Longevity?
AgingResearch.News: Longevity funziona su iPhone, iPad.
In quali lingue è disponibile AgingResearch.News: Longevity?
AgingResearch.News: Longevity è disponibile in 11 lingue, tra cui tedesco, inglese, spagnolo, francese, italiano, giapponese.
Chi sviluppa AgingResearch.News: Longevity?
AgingResearch.News: Longevity è sviluppata da PAPERFOOT AI PTE. LTD.. La classificazione per età su App Store è 12+.
Quali sono le alternative a AgingResearch.News: Longevity?
App simili su Debuts: Chaluu: Accessible Messaging, Vigia Brasília, Fanfold: News as Magazines.

Le valutazioni delle persone

Accedi per valutare questa app. Conta essere sinceri.

Ancora nessuna valutazione. L'hai provata? Sii il primo a valutarla.

Segnali di scoperta

Come l'IA e le persone scoprono AgingResearch.News: Longevity su Debuts
Pronta per l'IAIn parte
78% descritto per l'abbinamento con l'IA
Individuabile oraAttivaDati strutturati in questa pagina e API di Debuts

Dicci cosa ti piace. Ti scriviamo solo quando esce qualcosa di nuovo che fa al caso tuo, e spesso gli sviluppatori aggiungono un vantaggio per i tester.

Che tipo di app
Sul mio
Mostrami solo
Con che frequenza
Ti mandiamo un link di conferma. Non riceverai nulla finché non lo clicchi.